NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-003-2020-0-PCT-02 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY PCT PCT PCT/US2020/064412 Expired
NCI E-003-2020-0-CN-04 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY CN National Stage 202080086575.3 Pending
NIAID E-153-2019-1-CN-05 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE CN National Stage 202080096383.0 Pending
NIAID E-153-2019-1-EP-06 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE EP National Stage 20841798.0 Pending
NCI E-003-2020-0-EP-05 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY EP National Stage 20899103.4 Pending
NIAID E-153-2019-1-JP-09 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE JP National Stage 2022-535470 Pending
NCI E-003-2020-0-AU-03 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY AU National Stage 2020403013 Pending
NIAID E-153-2019-1-BR-03 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE BR National Stage BR112022011422-2 Pending
NIAID E-153-2019-1-AU-02 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE AU National Stage 2020402106 Pending
NCI E-147-2021-0-US-01 COMPOSITIONS AND METHODS FOR TREATING CANCER US 63/124,231 Abandoned
NCI E-003-2020-0-KR-07 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY KR National Stage 10-2022-7023239 Pending
NIAID E-153-2019-1-KR-10 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE KR National Stage 10-2022-7023549 Pending
NIAID E-153-2019-1-SG-12 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE SG National Stage 11202250095U Pending
NIAID E-153-2019-1-ZA-14 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE ZA National Stage 2022/06497 Pending
NIAID E-153-2019-1-CA-04 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE CA National Stage 3164343 Pending
NIAID E-153-2019-1-IN-08 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE IN National Stage 202217038319 Pending
NIAID E-153-2019-1-IL-07 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE IL National Stage 293666 Pending
NICHD E-026-2019-0-US-03 POLYPEPTIDES, NUCLEIC ACID MOLECULES, COMPOSITIONS, AND RELATED METHODS US National Stage 17/251,019 12054526 Issued PDF
NCI E-040-2012-0-US-60 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/117,335 11377660 Issued PDF
NCI E-040-2012-0-US-61 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/117,368 11359204 Issued PDF
NCI E-040-2012-0-US-59 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/117,311 11066674 Issued PDF
NIAID E-131-2020-7-PCT-01 Anti-Coronavirus Antibodies And Methods Of Use PCT PCT COMB PCT/US2020/063991 Expired
NIAID E-131-2020-7-CN-01 Anti-Coronavirus Antibodies And Methods Of Use CN National Stage 202080100619.3 Pending
NCATS E-114-2018-0-EP-05 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS EP National Stage 19728226.2 Pending
NIAID E-131-2020-7-US-02 Anti-Coronavirus Antibodies And Methods Of Use US ORD 17/116,588 Abandoned
NIAID E-131-2020-7-IL-18 Anti-Coronavirus Antibodies And Methods Of Use IL National Stage 296224 Pending
NIAID E-131-2020-7-AU-14 Anti-Coronavirus Antibodies And Methods Of Use AU National Stage 2020435452 Pending
NIAID E-131-2020-7-BR-15 Anti-Coronavirus Antibodies And Methods Of Use BR National Stage BR112022017986-3 Pending
NIAID E-131-2020-7-JP-01 Anti-Coronavirus Antibodies And Methods Of Use JP National Stage 2022-554810 Pending
NIAID E-131-2020-7-MX-20 Anti-Coronavirus Antibodies And Methods Of Use MX National Stage MX/a/2022/011142 Pending
NIAID E-131-2020-7-CA-16 Anti-Coronavirus Antibodies And Methods Of Use CA National Stage 3171237 Pending
NIAID E-131-2020-7-EG-17 Anti-Coronavirus Antibodies And Methods Of Use EG National Stage 1289/2022 Pending
NINDS E-198-2021-0-GB-01 UNC13A Disease Polymorphisms Lead To Increased Cryptic Exon Expression In Settings Of TDP-43 Deficiency GB 2019418.9 Expired
NIAID E-131-2020-7-ZA-19 Anti-Coronavirus Antibodies And Methods Of Use ZA National Stage 2022/10039 Pending
NIAID E-145-2011-0-US-17 PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA US DIV 17/115,317 12059418 Issued PDF
NHLBI E-025-2019-0-PCT-02 ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF PCT PCT PCT/US2020/063809 Expired
NCI E-145-2019-0-PCT-02 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF PCT PCT PCT/US2020/063732 Expired
NIAID E-145-2015-3-US-15 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US CON 17/115,026 Pending
NCI E-145-2019-0-EP-05 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF EP National Stage 20834060.4 Pending
NCI E-229-2014-0-EP-09 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation EP DIV 20212578.7 Pending
NCI E-145-2019-0-JP-06 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF JP National Stage 2022-535127 Pending
NCI E-145-2019-0-AU-03 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF AU National Stage 2020402752 Pending
NCI E-145-2019-0-CA-04 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF CA National Stage 3161573 Pending
NCI E-494-2013-0-US-24 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS US CON 17/113,570 11077182 Issued PDF
NIAID E-052-2023-0-US-01 Combination therapy of N6 and Cabotegravir as a Therapeutic Treatment for HIV US 63/122,031 Expired
NCI E-094-2018-0-CN-05 METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF CN National Stage 201980037634.5 Issued
NCI E-075-2018-0-DE-05 HEXAMERIC TETRAHEDRAL RNA NANOSTRUCTURES DE EP 19727193.5 Issued
NCI E-075-2018-0-GB-06 HEXAMERIC TETRAHEDRAL RNA NANOSTRUCTURES GB EP 19727193.5 Issued
NCI E-075-2018-0-EP-02 HEXAMERIC TETRAHEDRAL RNA NANOSTRUCTURES EP National Stage 19727193.5 Issued
NCATS E-262-2016-0-EP-07 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS EP DIV 20211957.4 Abandoned